Daniel Umbricht

1 session at 1 meeting

Topics

Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSchizophrenia & Psychosis

Sessions

39th ECNP Congress

October 10–13, 2026 · Munich, Germany · Full program

  • SymposiumS15 – Novel Therapies Symposium – showcasing clinical trials on emerging compounds and new medical devices

    October 12, 2026

    Trial results on emerging treatments including cannabidiol vs risperidone for cannabis-related psychosis (CANRISE), a novel oral NMDA antagonist, PDE10A inhibition in schizophrenia, and digital devices.

    Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSchizophrenia & Psychosis

Presents with

Alexandra Philipsen · Lone Baandrup · Mikołaj Matłoka · Susan L. Rossell · Viktoria Damgaard

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

Recurring meetings